New drug AMG 133 tested for how it affects stomach emptying in overweight individuals
NCT ID NCT07429032
First seen Feb 25, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This early-stage study tested the drug AMG 133 in 57 adults with overweight or obesity. The main goal was to see how the drug affects stomach emptying, measured by how the body processes acetaminophen. The study also checked for side effects and changes in appetite and food intake.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, 32117, United States
Conditions
Explore the condition pages connected to this study.